← Back to front page
United States · Platforms & data · TradingView

Johnson & Johnson looking to buy Ollin Biosciences for up to $3.4 billion, FT says

Published by TradingView · United States 11 h ago
Johnson & Johnson looking to buy Ollin Biosciences for up to $3.4 billion, FT says
TradingView

Detailed summary

Johnson & Johnson NYSE:JNJ is poised to buy privately held eye disease drug developer Ollin Biosciences for up to $3.4 billion, the Financial Times reported on Sunday, citing people familiar with the matter.Under the terms of the deal being discussed, J&J could pay Ollin’s backers $2.2 billion upfr…

Read the full article on TradingView Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingview.com)

Also worth reading